Jump to content
IndiaDivine.org

a very important distinction--number of participants in trial

Rate this topic


Guest guest

Recommended Posts



Ya know Bea what puzzles me is the use of (ONLY) 240 healthy adults...... when they state the people to first receive this new vaccine will be those most at risk, such as diabetics, the elderly, those with ongoing helath problems which make them more suceptible to getting ill if they catch this influenza...............

 

This vaccine has no adjuvants ok, but the multi-dose bottles do contain mercury.........

 

 

New England Journal of Medicine (NEJM

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...